Spyre Therapeutics Correlations
SYRE Stock | 27.75 0.08 0.29% |
The current 90-days correlation between Spyre Therapeutics and Milestone Pharmaceuticals is 0.35 (i.e., Weak diversification). The correlation of Spyre Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Spyre Therapeutics Correlation With Market
Very weak diversification
The correlation between Spyre Therapeutics and DJI is 0.49 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Spyre |
Moving together with Spyre Stock
0.66 | LPTX | Leap Therapeutics | PairCorr |
0.61 | PHVS | Pharvaris BV | PairCorr |
0.76 | PLRX | Pliant Therapeutics | PairCorr |
0.77 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.63 | SGMO | Sangamo Therapeutics Buyout Trend | PairCorr |
0.63 | CRVS | Corvus Pharmaceuticals | PairCorr |
Moving against Spyre Stock
0.46 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.44 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.4 | MNOV | MediciNova | PairCorr |
0.33 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
0.4 | ACIU | AC Immune | PairCorr |
0.38 | BDTX | Black Diamond Therap | PairCorr |
0.35 | ADAP | Adaptimmune Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Spyre Stock performing well and Spyre Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Spyre Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
IKNA | 0.90 | (0.11) | 0.00 | (0.09) | 0.00 | 1.80 | 5.87 | |||
ELYM | 3.87 | (0.92) | 0.00 | (2.63) | 0.00 | 6.21 | 34.87 | |||
HCWB | 13.10 | 3.70 | 0.32 | (0.97) | 8.25 | 22.00 | 352.85 | |||
RNXT | 3.47 | 0.47 | 0.09 | 1.00 | 3.88 | 7.55 | 40.06 | |||
TPST | 3.90 | (0.60) | 0.00 | (0.58) | 0.00 | 6.38 | 29.55 | |||
SCPH | 2.76 | (0.63) | 0.00 | (0.24) | 0.00 | 4.30 | 20.70 | |||
MIST | 1.85 | 0.22 | 0.13 | 0.26 | 1.57 | 7.19 | 18.66 | |||
MCRB | 4.93 | 0.32 | 0.04 | 1.12 | 5.57 | 10.84 | 28.84 | |||
LUMO | 2.35 | 0.27 | 0.03 | (0.28) | 2.95 | 5.95 | 16.25 |